FDA Import Refusal SCS-0135650-1/11/1 — GLAXOSMITHKLINE PHARMACEUTICALS
The FDA refused shipment SCS-0135650-1/11/1 from GLAXOSMITHKLINE PHARMACEUTICALS (India) on Nov 2, 2018. The refused product falls under Drugs and Biologics — LEVOTHYROXINE SODIUM (THYROID HORMONE). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 2, 2018
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66JCA01 LEVOTHYROXINE SODIUM (THYROID HORMONE)
- Charges
- 75